Author:
Bardin Laurent,Kleven Mark S,Barret-Grévoz Catherine,Depoortère Ronan,Newman-Tancredi Adrian
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference57 articles.
1. Assié MB, Cosi C, Koek W (1997). 5-HT1A receptor agonist properties of the antipsychotic nemonapride: comparison with bromerguride and clozapine. Eur J Pharmacol 334: 141–147.
2. Bantick RA, Deakin JFW, Grasby PM (2001). The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics ? J Psychopharmacol. 15: 37–46.
3. Bantick RA, Montgomery AJ, Malek N, Choudry T, Messa C, Deakin JFW et al (2000). Occupancy/downregulation of the 5-HT1A receptor by clozapine measured using PET scanning. J Psychopharmacol 14: PG20.
4. Bartoszyk GD, Van Amsterdam C, Greiner HE, Rautenberg W, Russ H, Seyfried CA (2004). Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile. J Neural Transm 111: 113–126.
5. Blier P, Ward NM (2003). Is there a role for 5-HT1A agonists in the treatment of depression? Biol Psychiatry 53: 193–203.
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献